UPDATE: Unilabs Offering Genomic Health's Oncotype DX Breast Cancer Test in UK
October 11, 2012
UPDATE: Unilabs Offering Genomic Health's Oncotype DX Breast Cancer Test in UK
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Deal with NewBridge Allows Genomic Health to Expand Oncotype DX into Africa, Middle East
August 13, 2012 / GenomeWeb Daily News - With 8 Percent Revenue Bump in Q1, Genomic Health Focus on Expanding Oncotype DX Franchise
May 8, 2013 / Pharmacogenomics Reporter - Data Supports Oncotype DX for Predicting Recurrence in Node-Positive Cancers, Guiding Radiation Therapy
March 13, 2013 / Pharmacogenomics Reporter - UK's NICE Recommends Use of Genomic Health's OncoType DX in Draft Guidance
February 19, 2013 / GenomeWeb Daily News - FDA Approves Dako's HER2 IQFISH Assay
February 15, 2013 / GenomeWeb Daily News